NUVL Research and Charts

NUVL - Nuvalent Inc Class A (Healthcare: Biotechnology)

Projected Earnings Date: 2025-02-11 (Delayed quote data 2025-01-03)

Last 80.78	Change ⇑ +0.79 (+0.99%)	Volume 564,830
	Open 80.43	High 81.89	Low 79.81

8EMA (Daily) 81.06	40EMA (Daily) 87.90	50EMA (Daily) 88.66	STO (Daily) 14.841	MACD Hist (Daily) -0.875
8EMA (Weekly) 86.693	40EMA (Weekly) 83.48	50EMA (Weekly) 80.69	STO (Weekly) 17.125	MACD Hist (Weekly) -4.895


Company Profile
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.